ΔNp63 expression in four carcinoma cell lines and the effect on radioresistance--a siRNA knockdown model

Maximilian Moergel1,2, Jutta Goldschmitt3, Marcus Stockinger4

  • 1Department of Oral and Maxillofacial Surgery, University of Mainz, Medical Center, Augustusplatz 2, 55131, Mainz, Germany. maximilian.moergel@unimedizin-mainz.de.

Abstract

Insights

Overexpression of delta Np63 alpha (ΔNp63α) in upper aerodigestive tract cancers may protect cells from radiation. Reducing ΔNp63α levels increased cell death, suggesting it as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiation Oncology

Background:

  • Delta Np63 alpha (ΔNp63α) is a key isoform of the p63 protein family.
  • p63 isoforms play critical roles in epithelial development and cancer.
  • The role of ΔNp63α in radioresistance of upper aerodigestive tract (UAT) cancers remains to be fully elucidated.

Purpose of the Study:

  • To investigate the expression of ΔNp63α in UAT carcinoma cell lines.
  • To determine the influence of ΔNp63α on radioresistance.
  • To evaluate ΔNp63α as a potential therapeutic target for UAT cancers.

Main Methods:

  • Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) to measure ΔNp63α expression.
  • Small interfering RNA (siRNA) to knockdown ΔNp63α expression.
  • Western blot to confirm knockdown effectiveness.
  • Terminal transferase dUTP nick end labeling (TUNEL) assay and WST-1 assay to assess apoptosis and cell viability post-irradiation.

Main Results:

  • All investigated UAT carcinoma cell lines exhibited varying levels of ΔNp63α expression.
  • Successful knockdown of ΔNp63α was achieved using siRNA.
  • Knockdown of ΔNp63α significantly increased apoptotic events and reduced cell viability in three out of four cell lines after irradiation.

Conclusions:

  • Overexpression of ΔNp63α confers radioresistance in UAT carcinoma cells.
  • Targeting ΔNp63α could enhance the efficacy of radiotherapy.
  • ΔNp63α may serve as a predictive biomarker for radiation response and a therapeutic target in UAT cancers.

Related Concept Videos